[{"id":"cf9f2b4a-201f-4caa-8789-84fd3a614f85","acronym":"","url":"https://clinicaltrials.gov/study/NCT05554341","created_at":"2023-06-18T20:08:30.389Z","updated_at":"2024-07-02T16:34:27.622Z","phase":"Phase 2","brief_title":"Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial","source_id_and_acronym":"NCT05554341","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" PDGFRA","pipe":" | ","alterations":" PDGFRA D842V • KIT L576P • KIT K642E • KIT V559 • KIT V559A • KIT W557","tags":["PDGFRA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PDGFRA D842V • KIT L576P • KIT K642E • KIT V559 • KIT V559A • KIT W557"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e paclitaxel • Tasigna (nilotinib)"],"overall_status":"Suspended","enrollment":" Enrollment 40","initiation":"Initiation: 07/14/2023","start_date":" 07/14/2023","primary_txt":" Primary completion: 07/01/2025","primary_completion_date":" 07/01/2025","study_txt":" Completion: 07/01/2025","study_completion_date":" 07/01/2025","last_update_posted":"2024-06-10"}]